CD40 signaling and plaque instability

Circulation Research

Volumn 89, Issue 12, 2001, Pages 1092-1103

  Schönbeck, Uwe ^a   Libby, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atherosclerosis; CD40; CD40L; Immunity; Inflammation

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANGIOGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; IMMUNITY; INFLAMMATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0035824895     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh2401.101272     Document Type: Review

References (137)

1. Lesion versus lumen
2. Atherosclerosis: An inflammatory disease
3. Atherosclerosis: The road ahead
4. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque
5. Polyclonal origin of T lymphocytes in human atherosclerotic plaques
6. Diversity of T-cell antigen receptor Vβ gene utilization in advanced human atheroma
7. CD40 and CD154 in cell-mediated immunity
8. CD40-CD40 ligand: A multifunctional receptor-ligand pair
9. CD40 and its ligand
10. CD154 (CD40 ligand)
11. The CD40/CD154 rcceptor/ligand dyad
12. Molecular and biological characterization of a murine ligand for CD40
13. Cloning of TRAP. A ligand for CD40 on human T cells
14. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity
15. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand
16. CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40
17. Expression of functional CD40 by vascular endothelial cells
18. CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression
19. Functional interactions of T cells with endcthelial cells: The role of CD40L-CD40-mediated signals
20. Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines
21. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis
22. Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor κB signal transducer and activation of transcription-1
23. CD40L (CD154) expression in human liver allografts during chronic ductopenic rejection
24. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection
25. Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions: Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (FcγRIII)
26. Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions
27. Bi-directional activation between human airway smooth muscle cells and T lymphocytes: Role in induction of altered airway responsiveness
28. Reduction of atherosclerosis in mice by inhibition of CD40 signalling
29. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
30. Expression of stromelysin-3 in atherosclerotic lesions: Regulation via CD40-CD40 ligand signaling in vitro and in vivo
31. Requirement for CD154 in the progression of atherosclerosis
32. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice
33. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
34. Dietary lipid lowering reduces tissue factor expression in rabbit atheroma
35. The antigen dose determines T helper subset development by regulation of CD40 ligand
36. Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation
37. 4+ T cells through LFA-3-mediated stabilization of mRNA
38. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes
39. Biological function of CD40 on human endothelial cells: Costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes
40. 4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice
41. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis
42. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice
43. CD154 stimulation of interleukin-12 synthesis in human endothelial cells
44. A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-γ treatment
45. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: Role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production
46. CD40 ligation enhances IL-15 production by tubular epithelial cells
47. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells in vitro and in the SCID mouse-human rheumatoid arthritis model in vivo
48. Expression of interleukin-15 in mouse and human atherosclerotic lesions
49. Human monocytes constitutively express membrane-bound, biologically active, and interferon-γ-upregulated interleukin-15
50. 4+ T cells in the absence of TCR ligation
51. IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells
52. Interleukin-15 up-regulates the expression of CD154 on synovial fluid T cells
53. CD40-CD40 ligand (CD154) engagement is required but may not be sufficient for human T helper 1 cell induction of interleukin-2- or interleukin-15-driven, contact-dependent, interleukin-1β production by monocytes
54. 4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis
55. Ligation of CD40 activates interleukin 1β-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1β
56. Tumor necrosis factor a and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells
57. A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy
58. CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive β-chemokines
59. Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: Induction of the synthetic phenotype: A possible clue to SMC differentiation in the process of atherogenesis
60. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques
61. 4+ T cell accumulation in rheumatoid arthritis synovium
62. CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets
63. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice
64. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
65. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis
66. Human vascular smooth muscle cells express receptors for CC chemokines
67. Chemokine receptors in human endothelial cells: Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines
68. Human vascular smooth muscle cells possess functional CCR5
69. Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells
70. Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells
71. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: A prominent role for neovascularization?
72. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: Implications for tubule formation
73. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo
74. Interleukin-15 promotes angiogenesis in vivo
75. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions
76. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants
77. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: Roles of the nuclear factor of activated T cells and cyclooxygenase 2
78. The contributions of cyclooxygenase-2 to tumor angiogenesis
79. IL-8 is an angiogenic factor in human coronary atherectomy tissue
80. Molecular determinants of atherosclerotic plaque vulnerability
81. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques
82. Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: A novel collagenolytic pathway suggested by transcriptional profiling
83. T cell rescue of monocytes from apoptosis: Role of the CD40-CD40L interaction and requirement for CD40-mediated induction of protein tyrosine kinase activity
84. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells
85. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: Induction of collagenase, stromelysin, and tissue factor
86. CD40 engagement induces monocyte procoagulant activity through an interleukin-10 resistant pathway
87. CD40 engagement on endothelial cells promotes tissue factor-dependent procoagulant activity
88. CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression
89. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40
90. CD40 ligation induces tissue factor expression in human vascular smooth muscle cells
91. The structural biology of expression and function of tissue factor
92. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis
93. A role for tissue factor in cell adhesion and migration mediated interaction with actin-binding protein 280
94. Tissue factor induces migration of cultured aortic smooth muscle cells
95. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
96. Soluble CD40L and cardiovascular risk in women
97. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
98. Phase 1 clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus
99. The Tnf and TNF receptor super-families: Integrating mammalian biology
100. RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function
101. Construction and analysis of a detailed three-dimensional model of the ligand binding domain of the human B cell receptor CD40
102. Structure of the murine CD40 ligand gene
103. A soluble form of TRAP (CD40 ligand) is rap dly released after T cell activation
104. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3
105. The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription
106. Transcriptional activity of the distal CD40 ligand promoter
107. Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching
108. The human gp39 promoter: Two distinct nuclear factors of activated T cell protein-binding elements contribute independently to transcriptional activation
109. Regulation of CD40L expression on natural killer cells by interleukin-12 and interferon γ: Its role in the elicitation of an effective antitumor immune response
110. CD40-mediated signaling in B cells: Balancing cell survival, growth, and death
111. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization
112. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling
113. Incorporation of an isoleucine zipper motif enhances the biological activity of soluble CD40L (CD154)
114. Regulation of CD40 function by its isoforms generated through alternative splicing
115. Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40
116. Different CD40-mediated signaling events require distinct CD40 structural features
117. Hodgkin disease: Pharmacologic intervention of the CD40-NF κB pathway by a protease inhibitor
118. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death
119. Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells
120. Tumor necrosis factor α-induced activation of c-jun N-terminal kinase is mediated by TRAF2
121. Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2
122. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice
123. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival
124. TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-κB activation
125. Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway
126. Tumour-necrosis-factor-receptor-associated factor 6, NF-κB-inducing kinase, and IκB kinases mediate IgE isotype switching in response to CD40
127. Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1
128. CD40-mediated signal transduction in human airway smooth muscle
129. CD40-mediated signaling in monocytic cells: Up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways
130. CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway: A target of interleukin (IL)-4 and IL-10 anti-inflammatory action
131. Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells
132. CD40 signaling in human dendritic cells is initiated within membrane rafts
133. Reduction of atherosclerosis despite hypercholesterolemia in lyn-deficient mice fed a high-fat diet
134. Activation of the Janus kinase 3-STAT5a pathway after CD40 triggering of human monocytes but not of resting B cells
135. Immunohistochemical analysis of in vivo patterns of TRAF-3 expression, a member of the TNF receptor-associated factor family
136. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction
137. NF-κB activation through IKK-I-dependent I-TRAF/TANK phosphorylation